Jyong Biotech Ltd. Ordinary Shares
- MENS
- NASDAQ
- Biotechnology
- Botanical Therapeutics
- Urology Treatments
$1.93
Today +4.89%Quote Oct 19, 2026, 08:00 PM UTC
−11.54%over the last month
Max drawdown −22.7%From 1-month high −22.7%3 months −20.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Jyong Biotech Ltd. Ordinary Shares
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
27
Market value
$146.7M
Quote Oct 19
Floor
$1.90
1.7% below price
Resistance
$2.00
3.4% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MENSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free